Call for Papers  

Article Details

Review Article

Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer

[ Vol. 29 , Issue. 1 ]


Erva Ozkan and Filiz Bakar-Ates*   Pages 41 - 55 ( 15 )


Ferroptosis, which is an iron-dependent, non-apoptotic cell death mechanism, has recently been proposed as a novel approach in cancer treatment. Bearing distinctive features and its exclusive mechanism have put forward the potential therapeutic benefit of triggering this newly discovered form of cell death. Numerous studies have indicated that apoptotic pathways are often deactivated in resistant cells, leading to a failure in therapy. Hence, alternative strategies to promote cell death are required. Mounting evidence suggests that drug-resistant cancer cells are particularly sensitive to ferroptosis. Given that cancer cells consume a higher amount of iron than healthy ones, ferroptosis not only stands as an excellent alternative to trigger cell death and reverse drug-resistance, but also provides selectivity in therapy. This review focuses specifically on overcoming drugresistance in cancer through activating ferroptotic pathways and brings together the relevant chemotherapeutics-based and nanotherapeutics-based studies to offer a perspective for researchers regarding the potential use of this mechanism in developing novel therapeutic strategies.


Ferroptosis, erastin, cancer, resistance, cisplatin, nanotherapeutics.


Ankara University, Faculty of Pharmacy, Department of Biochemistry, Ankara, Ankara University, Faculty of Pharmacy, Department of Biochemistry, Ankara

Read Full-Text article